The social production of hepatitis C risk among injecting drug users: a qualitative synthesis.
暂无分享,去创建一个
[1] D. Vlahov,et al. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. , 1993, Addiction.
[2] H. Klee,et al. Hepatitis C testing and injecting risk behaviour: the results of a UK based pilot study , 2004 .
[3] T. Rhodes,et al. The social structural production of HIV risk among injecting drug users. , 2005, Social science & medicine.
[4] C. Treloar. ‘You Sort of Switch Off’: Exploring Mindlessness in Injecting Drug Users’ Accounts of Blood , 2005, Journal of health psychology.
[5] C. Treloar,et al. Chronic Illness Experiences, Clinical Markers and Living with Hepatitis C , 2007, Journal of health psychology.
[6] T. Rhodes,et al. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. , 2004, Addiction.
[7] E. Plumridge,et al. Identity and the social construction of risk : injecting drug use , 1999 .
[8] E. Southgate,et al. What's in a virus? Folk understandings of hepatitis C infection and infectiousness among injecting drug users in Kings Cross, Sydney , 2005, International journal for equity in health.
[9] N. Beeching,et al. Understanding social stigma in women with hepatitis C. , 2004, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[10] S. Fraser,et al. Blood and bioidentity: ideas about self, boundaries and risk among blood donors and people living with hepatitis C. , 2004, Social science & medicine.
[11] T. Rhodes,et al. Beyond prevention? Injecting drug user narratives about hepatitis C , 2004 .
[12] S. Fraser. ‘It’s Your Life!’: Injecting Drug Users, Individual Responsibility and Hepatitis C Prevention , 2004, Health.
[13] S. Gifford,et al. The lived experience of men and women with hepatitis C: implications for support needs and health information. , 2004, Australian health review : a publication of the Australian Hospital Association.
[14] J. Parry,et al. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study , 2004, BMJ : British Medical Journal.
[15] J. Ellard. 'There is no profile it is just everyone': the challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users. , 2007, The International journal on drug policy.
[16] R. Garfein,et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. , 2002, American journal of epidemiology.
[17] R. Garfein,et al. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. , 2007, Drug and alcohol dependence.
[18] P. Bourgois,et al. The Everyday Violence of Hepatitis C Among Young Women Who Inject Drugs in San Francisco. , 2004, Human organization.
[19] D. D. Des Jarlais,et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas , 2006, AIDS.
[20] E. Murphy,et al. Qualitative research methods in health technology assessment: a review of the literature. , 1998, Health technology assessment.
[21] N. Wright,et al. Exploring risk perception and behaviour of homeless injecting drug users diagnosed with hepatitis C. , 2005, Health & social care in the community.
[22] J. Kaldor,et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection , 2001, Hepatology.
[23] Rohan Jayasuriya,et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. , 2006, Addiction.
[24] Belinda Crockett,et al. “Eyes Wide Shut”: Narratives of Women Living with Hepatitis C in Australia , 2004, Women & health.
[25] D. Easton,et al. Structural barriers and facilitators in HIV prevention: a review of international research , 2000, AIDS.
[26] N. Crofts,et al. A History of Peer-Based Drug-User Groups in Australia , 1995 .
[27] Heather Miller,et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial , 1999, The Lancet.
[28] Jenny Donovan,et al. Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care. , 2003, Social science & medicine.
[29] Edward A Belongia,et al. National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. , 2009, Annals of internal medicine.
[30] P. Miller. Scapegoating, self-confidence and risk comparison: The functionality of risk neutralisation and lay epidemiology by injecting drug users , 2005 .
[31] Richard Curtis,et al. Social capital or networks, negotiations, and norms? A neighborhood case study. , 2007, American journal of preventive medicine.
[32] L. Copeland. The drug user's identity and how it relates to Being Hepatitis C antibody positive: a qualitative study , 2004 .
[33] T. Rhodes,et al. Global estimates of prevalence of HCV infection among injecting drug users. , 2007, The International journal on drug policy.
[34] Robert Dingwall,et al. Accounts, interviews and observations , 1997 .
[35] M. Alary,et al. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users , 2007, International journal of STD & AIDS.
[36] E. Wood,et al. The public health and social impacts of drug market enforcement: A review of the evidence , 2005 .
[37] T. Rhodes. Risk theory in epidemic times: sex, drugs and the social organisation of ‘risk behaviour’ , 1997 .
[38] D. Gibson,et al. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. , 2001, AIDS.
[39] W. Edmunds,et al. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales , 2006, BMC infectious diseases.
[40] J. Bruneau,et al. Exploring the contingent reality of biomedicine: Injecting drug users, hepatitis C virus and risk , 2005 .
[41] D. D. Des Jarlais,et al. HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. , 2007, The International journal on drug policy.
[42] N. Wright,et al. Impact of a positive hepatitis C diagnosis on homeless injecting drug users: a qualitative study. , 2005, The British journal of general practice : the journal of the Royal College of General Practitioners.
[43] D. D. Des Jarlais,et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001 , 2005, AIDS.
[44] B. Berkhout,et al. Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users , 2007, European Journal of Epidemiology.
[45] S. Fraser,et al. Hepatitis C, blood and models of the body: New directions for public health , 2004 .
[46] Matthew Hickman,et al. Global overview of injecting drug use and HIV infection among injecting drug users , 2004, AIDS.
[47] Lee F. Monaghan,et al. Vocabularies of motive for illicit steroid use among bodybuilders. , 2002, Social science & medicine.
[48] T. Rhodes,et al. Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Serbia. , 2008, Social science & medicine.
[49] T. Rhodes,et al. Preventing hepatitis C: 'common sense', 'the bug' and other perspectives from the risk narratives of people who inject drugs. , 2004, Social science & medicine.
[50] T. Rhodes,et al. Trust, disruption and responsibility in accounts of injecting equipment sharing and hepatitis C risk , 2008 .
[51] C. Treloar,et al. Broadening discussions of "safe" in hepatitis C prevention: a close-up of swabbing in an analysis of video recordings of injecting practice. , 2008, The International journal on drug policy.
[52] P Vickerman,et al. Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study. , 2007, International journal of epidemiology.
[53] C. Seale,et al. Quality in Qualitative Research , 1999 .
[54] B. Paterson,et al. Living With the Stigma of Hepatitis C , 2008, Western journal of nursing research.
[55] É. Roy,et al. Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montréal. , 2007, The International journal on drug policy.
[56] L. Maher,et al. Có vay có tra (What goes around comes around): culture, risk and vulnerability to blood-borne viruses among ethnic Vietnamese injecting drug users. , 2008, Drug and alcohol review.
[57] R. Coutinho,et al. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users , 2007, Addiction.
[58] P. Bourgois,et al. The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. , 1998, Substance use & misuse.
[59] M. Busch,et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. , 2002, The Journal of infectious diseases.
[60] T. Wild,et al. Everybody's got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada. , 2007, The International journal on drug policy.
[61] D. D. Des Jarlais,et al. Hepatitis C Virus Infection Among Injection Drug Users: Survival Analysis of Time to Seroconversion , 2004, Epidemiology.
[62] T. Rhodes,et al. Managing seen and unseen blood associated with drug injecting: implications for theorising harm reduction for viral risk , 2004 .
[63] A. Wodak. Injecting nation: achieving control of hepatitis C in Australia. , 1997, Drug and alcohol review.
[64] P. Bourgois,et al. Theory, method, and power in drug and HIV-prevention research: a participant-observer's critique. , 1999, Substance use & misuse.
[65] S. Fraser,et al. ‘Spoiled identity’ in hepatitis C infection: The binary logic of despair , 2006 .
[66] K. Blankenship,et al. Structural interventions in public health , 2000, AIDS.
[67] T. Rhodes,et al. Accounting for unprotected sex: stories of agency and acceptability. , 2002, Social science & medicine.
[68] A. Wodak,et al. Effectiveness of sterile needle and syringe programmes , 2005 .
[69] C. Treloar,et al. Information exchange among injecting drug users: a role for an expanded peer education workforce , 2005 .
[70] D. Goldberg,et al. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature , 2002, Epidemiology and Infection.
[71] S. Fraser,et al. Putting at risk what we know: reflecting on the drug-using subject in harm reduction and its political implications. , 2006, Social science & medicine.
[72] M. MacDonald,et al. Transmission of hepatitis C virus: rates, routes, and cofactors. , 1996, Epidemiologic reviews.